Mylan launches generic anti-fungal drug

Drug maker launches first generic version of Vfend

PITTSBURGH — Mylan has launched the first generic version of a drug used to treat fungal infections, the company said Monday.

The drug maker announced the launch of voriconazole for oral suspension in the 40-mg-per-mL strength. The drug is the first generic version of Pfizer's Vfend, and as the first company to receive approval for a generic version, Mylan has 180 days in which to compete exclusively against Pfizer's product. The drug is used to treat invasive fungal infections.

The drug had sales of $17.1 million during the 12-month period that ended in June, according to IMS Health.

 

Login or Register to post a comment.